COVID-19: Pharma Supply Chain Security & Robustness During Global Pandemic

Join ISPE and a panel of subject matter experts as they discuss current challenges in keeping the supply chain operational during an ongoing global crisis like COVID-19.

Topics Covered

  • How companies are keeping their supply chain robust with a limited supply of key components
  • How to continue operations while ensuring worker safety (remote workforces or staggered shifts for social distancing, availability of PPE - face masks, sterile gowns, etc)
  • How to maintain the supply chain for life-saving therapies for patients outside of the COVID pandemic (insulin, etc.)
  • Challenges for developing treatments and therapies for the disease in the face of supply rationing and shortages including managing clinical trial participants
COVID-19 virus

This will be a live panel discussion with questions from the attendees. During the registration process, you will have the opportunity to submit questions for the panel, in addition to submitting questions during the live webinar.

Register


Meet the Speakers:

Moderators:

Nicholas C. Davies, M.Sc. B.Sc.
Managing Partner, Co-Chair Operations, Management COP
Verta Life Sciences
Session Moderator
Oliver Stauffer
CEO
PTI Inspection Systems
Question Moderator

Panel Speakers:

Christian Morello
Head of Global Supply Chain Planning and Programs Management
Lonza Pharma and Biotech
Jen Trone
Managing Director of Sales
UPS Supply Chain Solutions, Inc.
Joydeep Ganguly
Senior Vice President, Corporate Operations
Gilead Sciences Inc
Placeholder Person Graphic
Robert Handfield, PhD
Supply Chain Resource Cooperative, Poole College of Management
North Carolina State University
Timo Usinger
Vice President Customer Project Management/Procurement
Vetter Pharma-Fertigung GmbH & Co KG